Drugs / VTP-27999
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01217736 | Sep 2010 → Nov 2011 | impaired renal function disease | Vitae Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VTP-27999 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01217736 ↗ |
| Action | Inhibit | “direct renin inhibition by VTP-27999” NCT01217736 ↗ |
| Modality | Small molecule | — CHEMBL1276678 ↗ |